Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions

J Adiwidjaja, AJ McLachlan… - Expert opinion on drug …, 2017 - Taylor & Francis
Introduction: Curcumin has been extensively studied for its anti-cancer properties. While a
diverse array of in vitro and preclinical research support the prospect of curcumin use as an …

Approaches to minimize the effects of P‐glycoprotein in drug transport: A review

A Husain, V Makadia, GR Valicherla… - Drug development …, 2022 - Wiley Online Library
Abstract P‐glycoprotein (P‐gp) is a transporter protein that is come under the ATP binding
cassette family of proteins. It is situated on the surface of the intestine epithelium, where P …

The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells

AM Kurimchak, C Herrera-Montávez… - Science …, 2022 - science.org
Proteolysis-targeting chimeras (PROTACs) are a promising new class of drugs that
selectively degrade cellular proteins of interest. PROTACs that target oncogene products are …

[HTML][HTML] Cannabis constituents interact at the drug efflux pump BCRP to markedly increase plasma cannabidiolic acid concentrations

LL Anderson, MG Etchart, D Bahceci… - Scientific reports, 2021 - nature.com
Cannabis is a complex mixture of hundreds of bioactive molecules. This provides the
potential for pharmacological interactions between cannabis constituents, a phenomenon …

[HTML][HTML] Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways

N Dogra, A Kumar, T Mukhopadhyay - Scientific Reports, 2018 - nature.com
Drugs that are already clinically approved or experimentally tested for conditions other than
cancer, but are found to possess previously unrecognized cytotoxicity towards malignant …

[HTML][HTML] Structure–function relationships in the human P-glycoprotein (ABCB1): insights from molecular dynamics simulations

L Mora Lagares, Y Pérez-Castillo, N Minovski… - International Journal of …, 2021 - mdpi.com
P-Glycoprotein (P-gp) is a transmembrane protein belonging to the ATP binding cassette
superfamily of transporters, and it is a xenobiotic efflux pump that limits intracellular drug …

[HTML][HTML] Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer

SB Syed, H Arya, IH Fu, TK Yeh, L Periyasamy… - Scientific reports, 2017 - nature.com
Abstract P-glycoprotein (P-gp) is a drug transporter that effluxes chemotherapeutic drugs
and is implicated in the development of resistance of cancer cells to chemotherapeutic …

[HTML][HTML] Pharmacokinetic functions of human induced pluripotent stem cell-derived small intestinal epithelial cells

T Kabeya, S Mima, Y Imakura, T Miyashita… - Drug Metabolism and …, 2020 - Elsevier
To develop a novel intestinal drug absorption system using intestinal epithelial cells derived
from human induced pluripotent stem (iPS) cells, the cells must possess sufficient …

[HTML][HTML] Homology modeling of the human P-glycoprotein (ABCB1) and insights into ligand binding through molecular docking studies

L Mora Lagares, N Minovski… - International journal of …, 2020 - mdpi.com
The ABCB1 transporter also known as P-glycoprotein (P-gp) is a transmembrane protein
belonging to the ATP binding cassette super-family of transporters; it is a xenobiotic efflux …

[HTML][HTML] Inflammation induces changes in the functional expression of P-gp, BCRP, and MRP2: an overview of different models and consequences for drug disposition

S Saib, X Delavenne - Pharmaceutics, 2021 - mdpi.com
The ATP-binding cassette (ABC) transporters play a key role in drug pharmacokinetics.
These membrane transporters expressed within physiological barriers can be a source of …